Stephane Bello
Analyst · Matt Chesler with Deutsche Bank
Yes, absolutely, Matt, and it's an excellent question. If you look at 2012, our depreciation and amortization expense was about $18 million, up in '12 from '11 so it moved from, if I recall correctly, 8.7% of revenue. And for 2013, we are saying it's going to go up again and approach 9.5% of revenue. So effectively, what we see now is a lot of the product development, capital spending that was associated with Eikon and Elektron is flowing through the P&L. Let me give you one interesting anecdote over the 3-year period going from 2009, '10 and '11, we spent close to $0.5 billion on building Eikon and Elektron. During the 3 years, however, the depreciation and amortization expense, we took, because the products, who were not yet in service, was less than $100 million. So that's what's essentially creating the disconnect. What you're seeing is, effectively, the CapEx that we incur back in these years is now flowing through the P&L. This is just accounting. This is just the way it goes. That's why Jim and I are very much focusing the organization on this cash OI metric because we say what matters is what we control today, and what we can control today is the level of CapEx that we incur in 2012 and that we're going to incur in 2013, and that's very much what we are essentially incentivizing the leaders of the business to, which is the difference, what we did in the past. So hopefully, that answers your question, Matt.